Cargando…

Neoadjuvant therapy of locally/regionally advanced melanoma

Locally/regionally advanced melanoma confers a major challenge in terms of surgical and medical management. Surgical treatment carries the risks of surgical morbidities and potential complications that could be lasting. In addition, these patients continue to have a high risk of relapse and death de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khunger, Arjun, Buchwald, Zachary S., Lowe, Michael, Khan, Mohammad K., Delman, Keith A., Tarhini, Ahmad A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669845/ https://www.ncbi.nlm.nih.gov/pubmed/31391869 http://dx.doi.org/10.1177/1758835919866959

Ejemplares similares

Immune Monitoring of the Circulation and the Tumor Microenvironment in Patients with Regionally Advanced Melanoma Receiving Neoadjuvant Ipilimumab
por: Tarhini, Ahmad A., et al.
Publicado: (2014)

Neoadjuvant therapy for locally advanced melanoma: new strategies with targeted therapies
por: La Greca, Michele, et al.
Publicado: (2014)

The emergence of neoadjuvant therapy in advanced melanoma
por: Sun, James, et al.
Publicado: (2019)

Phenotypic and functional testing of circulating regulatory T cells in advanced melanoma patients treated with neoadjuvant ipilimumab
por: Retseck, Janet, et al.
Publicado: (2016)

Neoadjuvant ipilimumab (3 mg/kg or 10 mg/kg) and high dose IFN-α2b in locally/regionally advanced melanoma: safety, efficacy and impact on T-cell repertoire
por: Tarhini, Ahmad, et al.
Publicado: (2018)

Impact of Reconstruction on Oncologic Outcomes for Patients with Melanoma after Wide Local Excision: A High-Volume, Quaternary-Referral Center Experience
por: Turgeon, Michael K., et al.
Publicado: (2023)

Multimarker scores of Th1 and Th2 immune cellular profiles in peripheral blood predict response and immune related toxicity with CTLA4 blockade and IFNα in melanoma
por: Khunger, Arjun, et al.
Publicado: (2021)

Adjuvant Therapy: Melanoma
por: Davar, Diwakar, et al.
Publicado: (2011)

Neoadjuvant Therapy for Locally Advanced Esophageal Cancers
por: Huang, Runkai, et al.
Publicado: (2022)

The Current State of Neoadjuvant Therapy in Resectable Advanced Stage Melanoma
por: Bushara, Omar, et al.
Publicado: (2023)

Systemic adjuvant therapy for high-risk cutaneous melanoma
por: Kobeissi, Iyad, et al.
Publicado: (2022)

Neoadjuvant therapy for melanoma: rationale for neoadjuvant therapy and pivotal clinical trials
por: Witt, Russell G., et al.
Publicado: (2022)

Neoadjuvant immunotherapy of locoregionally advanced solid tumors
por: Tarhini, Ahmad A, et al.
Publicado: (2022)

CTLA-4 blockade and interferon-α induce proinflammatory transcriptional changes in the tumor immune landscape that correlate with pathologic response in melanoma
por: Khunger, Arjun, et al.
Publicado: (2021)

Dabrafenib in combination with trametinib in the treatment of patients with BRAF V600-positive advanced or metastatic non-small cell lung cancer: clinical evidence and experience
por: Khunger, Arjun, et al.
Publicado: (2018)

Adjuvant and neoadjuvant therapies in melanoma
por: Lim, Kok Haw Jonathan, et al.
Publicado: (2020)

Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma
por: Tarhini, Ahmad A., et al.
Publicado: (2015)

Not Waiting to Progress; How the COVID-19 Pandemic Nudged Neoadjuvant Therapy for Stage III Locally Advanced Melanoma Patients
por: Kinaschuk, Katie, et al.
Publicado: (2023)

Adjuvant Therapy for High-Risk Melanoma: An In-Depth Examination of the State of the Field
por: Eljilany, Islam, et al.
Publicado: (2023)

Developments and challenges in neoadjuvant therapy for locally advanced pancreatic cancer
por: Zhou, Bo, et al.
Publicado: (2023)

Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer
por: Ott, Oliver J., et al.
Publicado: (2021)

Complete and Durable Response After Radiation Therapy to Primary Tumor Site of a Patient With Metastatic Anorectal Mucosal Melanoma With Oligoprogression on Nivolumab
por: Wallington, David G., et al.
Publicado: (2020)

The use of immunotherapy in the treatment of melanoma
por: Achkar, Tala, et al.
Publicado: (2017)

Comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer
por: Zhu, Shaoyu, et al.
Publicado: (2019)

The Effect of Obesity on Response to Neoadjuvant Therapy in Locally Advanced Gastric Cancer
por: Sakin, Aysegul, et al.
Publicado: (2020)

The Present and Future of Neoadjuvant and Adjuvant Therapy for Locally Advanced Gastric Cancer
por: Koerner, Anna S., et al.
Publicado: (2023)

Case report: Neoadjuvant systemic therapy for melanoma
por: Gabuniya, Natiya, et al.
Publicado: (2020)

Effect of skeletal muscle loss during neoadjuvant imatinib therapy on clinical outcomes in patients with locally advanced GIST
por: Ding, Ping’an, et al.
Publicado: (2022)

Locally advanced thymoma; does neoadjuvant chemotherapy make a difference?
por: Abdel Jalil, Riad, et al.
Publicado: (2023)

Recent advances in neoadjuvant therapy for breast cancer
por: Potter, David A, et al.
Publicado: (2021)

Neoadjuvant chemotherapy for locally advanced cervical cancer
por: Iwata, Takashi, et al.
Publicado: (2016)

Neoadjuvant chemotherapy in locally advanced duodenal adenocarcinoma
por: Velandia, Carlos, et al.
Publicado: (2018)

Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
por: Papaccio, Federica, et al.
Publicado: (2020)

Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer
por: Sugiyama, T, et al.
Publicado: (1999)

Total neoadjuvant therapy in locally advanced rectal cancer: Role of systemic chemotherapy
por: Yoo, Ri Na, et al.
Publicado: (2019)

The Current Evidence on Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma
por: Oh, Dongryul, et al.
Publicado: (2020)

Meta-analysis of FOLFIRINOX-based neoadjuvant therapy for locally advanced pancreatic cancer
por: Chen, Zhiliang, et al.
Publicado: (2021)

Vascular calcification and response to neoadjuvant therapy in locally advanced rectal cancer: an exploratory study
por: Knight, Katrina A., et al.
Publicado: (2021)

Case Report: Durable complete pathologic response and organ preservation following ipilimumab and nivolumab for locally advanced primary vaginal mucosal melanoma
por: Tarhini, Ahmad A., et al.
Publicado: (2022)

Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer
por: Cleary, James M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kvm7vjtj7moropsh2d1fvoa8ch